HarleyLAB receives new NIH funding and joins the NCI Cancer Tissue Engineering Collaborative!

Dr. Harley is the PI of a new R01 research award from the National Institutes of Health entitled, ‘Perivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma.’ Dr. Harley is leading a team, including Co-Investigators Dr. Paul Hergenrother & Dr. Time Fan (Illinois), Dr. Rebecca Riggins (Georgetown), and Dr. Jann Sarkaria (Mayo) to develop a cancer tissue engineering program to investigate pathophysiological processes responsible for invasive spreading, therapeutic resistance, and poor survival in glioblastoma, the most common and lethal form of primary brain cancer. Congrats all!

This is exciting news as this award also provides the opportunity for the HarleyLAB to join the NCI Cancer Tissue Engineering Collaborative (CTEC) program, and initiative to help push the boundaries of how tissue engineering technologies can be exploited to accelerate diagnosis and treatment of cancer!